Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

BACKGROUND: Coadministration of mometasone furoate (MF) and formoterol fumarate (F) produces additive effects for improving symptoms and lung function and reduces exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the relative systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosoglou, Teddy, Hubbell, James, Xuan, Fengjuan, Cutler, David L, Meehan, Alan G, Kantesaria, Bhavna, Wittmer, Bret A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595976/
https://www.ncbi.nlm.nih.gov/pubmed/23525511
http://dx.doi.org/10.2147/COPD.S36592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595976/
https://www.ncbi.nlm.nih.gov/pubmed/23525511
http://dx.doi.org/10.2147/COPD.S36592

Ejemplares similares